1981 related articles for article (PubMed ID: 17636706)
21. Antidepressants for insomnia in adults.
Everitt H; Baldwin DS; Stuart B; Lipinska G; Mayers A; Malizia AL; Manson CC; Wilson S
Cochrane Database Syst Rev; 2018 May; 5(5):CD010753. PubMed ID: 29761479
[TBL] [Abstract][Full Text] [Related]
22. WITHDRAWN: Selective serotonin reuptake inhibitors (SSRIs) versus other antidepressants for depression.
Geddes JR; Freemantle N; Mason J; Eccles MP; Boynton J
Cochrane Database Syst Rev; 2007 Jul; 2006(3):CD001851. PubMed ID: 17636689
[TBL] [Abstract][Full Text] [Related]
23. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.
Anderson IM
J Affect Disord; 2000 Apr; 58(1):19-36. PubMed ID: 10760555
[TBL] [Abstract][Full Text] [Related]
24. Mirtazapine versus other antidepressive agents for depression.
Watanabe N; Omori IM; Nakagawa A; Cipriani A; Barbui C; Churchill R; Furukawa TA
Cochrane Database Syst Rev; 2011 Dec; (12):CD006528. PubMed ID: 22161405
[TBL] [Abstract][Full Text] [Related]
25. Discontinuation rates of SSRIs and tricyclic antidepressants: a meta-analysis and investigation of heterogeneity.
Hotopf M; Hardy R; Lewis G
Br J Psychiatry; 1997 Feb; 170():120-7. PubMed ID: 9093499
[TBL] [Abstract][Full Text] [Related]
26. Antidepressants for people with epilepsy and depression.
Maguire MJ; Weston J; Singh J; Marson AG
Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010682. PubMed ID: 25464360
[TBL] [Abstract][Full Text] [Related]
27. Newer generation antidepressants for depressive disorders in children and adolescents.
Hetrick SE; McKenzie JE; Cox GR; Simmons MB; Merry SN
Cochrane Database Syst Rev; 2012 Nov; 11(11):CD004851. PubMed ID: 23152227
[TBL] [Abstract][Full Text] [Related]
28. Citalopram versus other anti-depressive agents for depression.
Cipriani A; Purgato M; Furukawa TA; Trespidi C; Imperadore G; Signoretti A; Churchill R; Watanabe N; Barbui C
Cochrane Database Syst Rev; 2012 Jul; 7(7):CD006534. PubMed ID: 22786497
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease.
Pollok J; van Agteren JE; Carson-Chahhoud KV
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012346. PubMed ID: 30566235
[TBL] [Abstract][Full Text] [Related]
30. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and tolerability of moclobemide in comparison with placebo, tricyclic antidepressants, and selective serotonin reuptake inhibitors in elderly depressed patients: a clinical overview.
Amrein R; Stabl M; Henauer S; Affolter E; Jonkanski I
Can J Psychiatry; 1997 Dec; 42(10):1043-50. PubMed ID: 9469236
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis.
Arroll B; Macgillivray S; Ogston S; Reid I; Sullivan F; Williams B; Crombie I
Ann Fam Med; 2005; 3(5):449-56. PubMed ID: 16189062
[TBL] [Abstract][Full Text] [Related]
33. Amitriptyline v. the rest: still the leading antidepressant after 40 years of randomised controlled trials.
Barbui C; Hotopf M
Br J Psychiatry; 2001 Feb; 178():129-44. PubMed ID: 11157426
[TBL] [Abstract][Full Text] [Related]
34. Antidepressants for people with epilepsy and depression.
Maguire MJ; Marson AG; Nevitt SJ
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531
[TBL] [Abstract][Full Text] [Related]
35. A comparison of side effects of selective serotonin reuptake inhibitors and tricyclic antidepressants in older depressed patients: a meta-analysis.
Wilson K; Mottram P
Int J Geriatr Psychiatry; 2004 Aug; 19(8):754-62. PubMed ID: 15290699
[TBL] [Abstract][Full Text] [Related]
36. Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.
Song F; Freemantle N; Sheldon TA; House A; Watson P; Long A; Mason J
BMJ; 1993 Mar; 306(6879):683-7. PubMed ID: 8471919
[TBL] [Abstract][Full Text] [Related]
37. SSRIS versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability.
Anderson IM
Depress Anxiety; 1998; 7 Suppl 1():11-7. PubMed ID: 9597346
[TBL] [Abstract][Full Text] [Related]
38. Drop-out rates in placebo-controlled trials of antidepressant drugs: A systematic review and meta-analysis based on clinical study reports.
Sharma T; Guski LS; Freund N; Meng DM; Gøtzsche PC
Int J Risk Saf Med; 2019; 30(4):217-232. PubMed ID: 31561390
[TBL] [Abstract][Full Text] [Related]
39. Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis.
Montgomery SA; Kasper S
Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():33-40. PubMed ID: 7622822
[TBL] [Abstract][Full Text] [Related]
40. Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis.
Trindade E; Menon D; Topfer LA; Coloma C
CMAJ; 1998 Nov; 159(10):1245-52. PubMed ID: 9861221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
